Prolevare

Authorised

This medicine is authorised for use in the European Union

oclacitinib maleate

Overview

Up-to-date information on this veterinary medicinal product is available on the Veterinary Medicines Information website.

Product details

• Name of medicine:
  Prolevare
• Active substance:
  oclacitinib maleate
• International non-proprietary name (INN) or common name:
  oclacitinib maleate

Pharmacotherapeutic group

• Other dermatological preparations
• Dermatologicals
• Agents for dermatitis, excluding corticosteroids
• oclacitinib

Authorisation details

• EMA product number:
  EMEA/V/C/006117

Assessment history

Initial marketing authorisation documents

CVMP summary of positive opinion for Prolevare

AdoptedReference Number: EMA/CVMP/66932/2023